Findings support development of γδ T cells for gastrointestinal diseases GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies
Read moreQ BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run
Read moreQ BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run
Read moreQ BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run
Read moreExclusive worldwide licence deal adding to Carrick”s rapid pipeline expansion Preparations for pivotal studies underway Dr. George Golumbeski appointed as
Read moreThe global Bitumen Market is estimated to develop at a substantial CAGR for the duration of the prediction due to
Read more
‘The opening of operations for CRB in Germany strategically aligns with our clients” growth in the region over the last
Read moreRegen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), reports its researchers have identified a series of small molecule drugs that
Read more
Purchase expands Avison Young”s U.K. footprint and adds eight Principals Mark E. Rose, Chair and CEO of Avison Young, the world”s
Read more4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company”s Chief
Read more